2020 Carbapenemase Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--US, Europe, Japan--Hospitals, Commercial and Public Health Labs, POC Locations

The report presents a detailed analysis of the Carbapenemase diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

List of Tables

France Carbapenemase Test Volume and Diagnostics Sales Forecast
Germany Carbapenemase Test Volume and Diagnostics Sales Forecast
Italy Carbapenemase Test Volume and Diagnostics Sales Forecast
Japan Carbapenemase Test Volume and Diagnostics Sales Forecast
Spain Carbapenemase Test Volume and Diagnostics Sales Forecast
U.K. Carbapenemase Test Volume and Diagnostics Sales Forecast
U.S.A. Carbapenemase Test Volume and Diagnostics Sales Forecast


I. Introduction
II. Worldwide Test Overview,
Technologies and Instrumentation
A. Background, Diagnostic Tests, Vaccines and Drugs
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
III. Country Analyses: Sales and Volume Forecasts
IV. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako

2020 Denmark Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective

USD 2450 View Report

2020 Czech Republic Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective

USD 2450 View Report

Carbapenemase Diagnostics Market: Test Volume and Sales Forecasts by Country, 2019-2023--US, Europe, Japan

This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. List of TablesFrance Carbapenemase Test Volume and Diagnostics Sales Forecast

USD 750 View Report

2019 Carbapenemase Diagnostics Market: Test Volume and Sales Forecasts by Country--US, Europe, Japan

This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. List of TablesFrance Carbapenemase Test Volume and Diagnostics Sales ForecastGermany

USD 950 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available